Collected data indicate that SPARC can be expressed by both cancer cells and stromal cells, especially TAMs, and realize its anti-tumor activity by inhibiting angiogenesis and decreasing cancer cell invasion and metastatic spread. This evidence concerns the gene SPARC and neoplasm.